Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Kaye

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Archives of Neurology|December 17, 2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?Christopher M Clark, Sharon Xie, Jesse Chittams, et al.
Acta Neuropathologica|July 27, 2007
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseasesHanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, et al.
Neurobiology of Aging|April 21, 2009
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer diseaseJoseph L Price, Daniel W McKeel, Virginia D Buckles, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 2019
A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in AgingEmily C Duggan, Andrea M Piccinin, Sean Clouston, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's diseaseAlex E Roher, Chera L Esh, Tyler A Kokjohn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Archives of Neurology|January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trialsMichael Grundman, Ronald C Petersen, Steven H Ferris, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|June 13, 2019
A Coordinated Multi-study Analysis of the Longitudinal Association Between Handgrip Strength and Cognitive Function in Older AdultsAndrea R Zammit, Andrea M Piccinin, Emily C Duggan, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Acta Neuropathologica Communications|August 6, 2021
Predictors of cognitive impairment in primary age-related tauopathy: an autopsy studyMegan A Iida, Kurt Farrell, Jamie M Walker, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Archives of Neurology|December 17, 2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?Christopher M Clark, Sharon Xie, Jesse Chittams, et al.
Acta Neuropathologica|July 27, 2007
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseasesHanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, et al.
Neurobiology of Aging|April 21, 2009
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer diseaseJoseph L Price, Daniel W McKeel, Virginia D Buckles, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 2019
A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in AgingEmily C Duggan, Andrea M Piccinin, Sean Clouston, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's diseaseAlex E Roher, Chera L Esh, Tyler A Kokjohn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Archives of Neurology|January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trialsMichael Grundman, Ronald C Petersen, Steven H Ferris, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|June 13, 2019
A Coordinated Multi-study Analysis of the Longitudinal Association Between Handgrip Strength and Cognitive Function in Older AdultsAndrea R Zammit, Andrea M Piccinin, Emily C Duggan, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Acta Neuropathologica Communications|August 6, 2021
Predictors of cognitive impairment in primary age-related tauopathy: an autopsy studyMegan A Iida, Kurt Farrell, Jamie M Walker, et al.
Pageof 18